OTHER PUBLICATIONS & ABSTRACTS
Other Data
Evidence / Other
Prognostic Value of MammaPrint in Diverse Populations: Evaluating Racial Disparities in Breast Cancer Outcomes
Publication: JCO Precis Oncol. 2026 Apr;10(4):e2500926. doi: 10.1200/PO-25-00926. Epub 2026 Apr 9. Authors: Reine Abou Zeidane, Samuel Lichtman-Mikol, Courtney Pisano, Benjamin Hauk, Yilun Sun, Priyanka S Rana, Citlally Lopez-Flores, Breanna N McBean, Kassidy M Jungles, Trisha Lal, Nihit Mehta, Philip Bomeisl, Amanda L Amin, Alberto J Montero, Siran Koroukian, Read More
Identification of racial disparities across MammaPrint and BluePrint subtypes in HR+HER2- breast cancer
Publication: npj Breast Cancer, Article number: (2026) Authors: Sonya Reid; Lindsay Venton; Jennifer G. Whisenant; Anne E. Weidner; Jennifer Wei; Harshini Ramaswamy; Christa Dreezen; Nicole Chmielewski-Stivers;Andrea R. Menicucci; William Audeh; Tuya Pal Title: Identification of racial disparities across MammaPrint and BluePrint subtypes in HR+HER2– breast cancer Abstract: We compared Read More
FLEX: From Genomic Profiling to Real-World Insights in 30,000 Patients with Early-Stage Breast Cancer
Publication: SABCS 2025, Presentation ID: PS5-09-19 Authors: Gold et al. Title: FLEX: From Genomic Profiling to Real-World Insights in 30,000 Patients with Early-Stage Breast Cancer Introduction: Treatment approaches for early-stage breast cancer (EBC) have advanced significantly in recent decades, with the addition of HER2-targeted therapies, immunotherapy, and personalized chemotherapy. Read More
Distinct Immune and Metabolic profiles in Latin American Breast Cancer Patients With Obesity Enrolled in FLEX
Publication: SABCS 2025, Presentation ID: PS4-09-09 Authors: Mazo Canola et al. Title: Distinct Immune and Metabolic profiles in Latin American Breast Cancer Patients With Obesity Enrolled in FLEX Introduction: Latin American (LA) women are more often diagnosed with aggressive early breast cancer (EBC) than Non-Hispanic White (NHW) women1. Prior Read More
Clinicopathologic and Molecular Characterization of Low-Grade, Early-Stage, and HER2-Positive Invasive Breast Carcinoma
Publication: American Journal of Clinical Pathology, 2025, Vol. 163, No. 6Authors: Natasha Hunter, MD; Lisa Han, MD; Haley Corbin, MD; Eric Q. Konnick, MD, MS, ; William R. Gwin III, MD; Shaveta Vinayak, MD; Hannah Linden, MD; William Audeh, MD; Lavanya Samraj, MD, MS; Andrea R. Menicucci, PhD; FLEX Investigators Read More
Association of MammaPrint and Clinical Outcomes by Race Among 5000 Individuals With HR+HER2- Early-Stage Breast Cancer Enrolled in FLEX
Publication: ASCO® 2025 Authors: Erin Cobain, Priyanka Sharma, Kent Hoskins, Michael Berry, Gregory Vidal, Jamie Alberty, Nicole Gordon, Harshini Ramaswamy, Nicole Stivers, Andrea Menicucci, William Audeh, Joyce O’Shaughnessy Title: Association of MammaPrint and clinical outcomes by race among 5000 individuals with HR+HER2- early stage breast cancer enrolled in FLEX Read More
High Concordance of 70-Gene Recurrence Risk Signature and 80-Gene Molecular Subtyping Signature Between Core Needle Biopsy and Surgical Resection Specimens in Early-Stage Breast Cancer
Publication: J Surg Oncol. 2022;125:596–602. Authors: Jennifer A. Crozier MD | Julie Barone DO | Pat Whitworth MD |Abraham Cheong MD | Robert Maganini MD | Jose Perez Tamayo MD | Patricia Dauer PhD | Shiyu Wang MS | William Audeh MD | Annuska M. Glas PhD Title: High Read More